This data driven report contains over 50 links to online copies of actual inflammatory bowel disease deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal. http://www.researchmoz.us/inflammatory-bowel-disease-partnering-2010-2015-report.html

1. Inflammatory Bowel Disease Partnering 2010-2015
The Inflammatory Bowel Disease Partnering 2010-2015 report provides understanding and access to the inflammatory bowel disease partnering deals and
agreements entered into by the worlds leading healthcare companies.
Trends in inflammatory bowel disease partnering deals Top inflammatory bowel disease deals by value Deals listed by company A-Z, industry sector, stage of
development, technology type
The Inflammatory Bowel Disease Partnering 2010-2015 provides understanding and access to the inflammatory bowel disease partnering deals and agreements
entered into by the worlds leading healthcare companies.
The report provides an analysis of inflammatory bowel disease partnering deals. The majority of deals are discovery or development stage whereby the licensee
obtains a right or an option right to license the licensors inflammatory bowel disease technology. These deals tend to be multicomponent, starting with
collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you
can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in
terms of how payments are triggered – contract documents provide this insight where press releases do not.
This data driven report contains over 50 links to online copies of actual inflammatory bowel disease deals and contract documents as submitted to the Securities
Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective
partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from
the deal.
The initial chapters of this report provide an orientation of inflammatory bowel disease partnering trends.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in partnering since 2010, including a summary of deals by
industry sector, stage of development, deal type, and technology type.
Chapter 3 provides an overview of the average deal terms since 2010. The chapter includes deals with a stage of development announced by headline value,
upfront value, milestone value and royalty rate. Numerous tables outline financial trends.
Chapter 4 provides an overview of the most active dealmakers, top dealmakers by value, active big pharma and big biotech dealmakers including contract
documents where available.
Chapter 5 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of
development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of
the deal record, and where available the contract document, providing easy access to each contract document on demand.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of
inflammatory bowel disease technologies and products.
Report scope
Inflammatory Bowel Disease Partnering 2010-2015 is intended to provide the reader with an in-depth understanding and access to inflammatory bowel disease
trends and structure of deals entered into by leading companies worldwide.
This data driven report includes:
Trends in inflammatory bowel disease dealmaking in the biopharma industry since 2010 Access to summary headline, upfront, milestone and royalty data
Access to over 50 inflammatory bowel disease deals The leading inflammatory bowel disease deals by value since 2010
In Inflammatory Bowel Disease Partnering 2010-2015, the available deals are listed by:
Headline value Upfront payment value Royalty rate value Company A-Z Industry sector Stage of development at signing Deal component type Technology
type
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract
document on demand.
table Of Content
executive Summary
chapter 1 – Introduction
chapter 2 – Trends In Inflammatory Bowel Disease Partnering
2.1. Introduction
2.2. Inflammatory Bowel Disease Partnering Over The Years
2.3. Inflammatory Bowel Disease Partnering By Deal Type
2.4. Inflammatory Bowel Disease Partnering Industry Sector
2.5. Inflammatory Bowel Disease Partnering By Stage Of Development
2.6. Inflammatory Bowel Disease Partnering By Technology Type
chapter 3 – Average Deal Terms For Inflammatory Bowel Disease
3.1 Introduction
3.2 Average Deal Terms For Inflammatory Bowel Disease
3.3 Inflammatory Bowel Disease Headline Values With Median Calculation
3.4 Inflammatory Bowel Disease Upfront Values With Median Calculation
3.5 Inflammatory Bowel Disease Milestone Values With Median Calculation
Inflammatory Bowel Disease Partnering 2010-2015

2. 3.6 Inflammatory Bowel Disease Royalty Rates With Median Calculation
chapter 4 – Active Inflammatory Bowel Disease Dealmakers
4.1. Introduction
4.2 Most Active Inflammatory Bowel Disease Dealmakers
4.3. Top Inflammatory Bowel Disease Deals By Value
4.4 Big Pharma Deal Activity
4.5 Big Biotech Deal Activity
chapter 5 – Inflammatory Bowel Disease Dealmaking Directory
5.1. Introduction
5.2. Company A-z
5.3. By Deal Type
5.4. By Industry Sector
5.5. By Stage Of Development
5.6. By Technology Type
chapter 6 – Partnering Resource Center
6.1. Online Partnering
6.2. Partnering Events
6.3. Further Reading On Dealmaking
appendices
appendix 1 – Deal Type Definitions
about Wildwood Ventures
current Partnering
current Agreements
recent Report Titles From Current Partnering
order Form – Reports
order Form – Subscription Access Products
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
Sales Team,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Inflammatory Bowel Disease Partnering 2010-2015